92 related articles for article (PubMed ID: 16288323)
1. [Multivariate analysis of the prognostic factors in 230 surgically treated oral mucosal malignant melanomas].
Liu YS; Yang CH; Sun YF; Geng B; Yuan KF
Shanghai Kou Qiang Yi Xue; 2005 Oct; 14(5):466-71; discussion 471-2. PubMed ID: 16288323
[TBL] [Abstract][Full Text] [Related]
2. [Effect of interferon alfa therapy on malignant melanoma of oral mucosa].
Liu YS; Zhang WD; Yang CH; Sun YF; Geng B
Shanghai Kou Qiang Yi Xue; 2006 Jun; 15(3):263-8. PubMed ID: 16862358
[TBL] [Abstract][Full Text] [Related]
3. Multifactorial Analysis of Prognostic Factors and Survival Rates Among 706 Mucosal Melanoma Patients.
Cui C; Lian B; Zhou L; Song X; Zhang X; Wu D; Chi Z; Si L; Sheng X; Kong Y; Tang B; Mao L; Wang X; Li S; Dai J; Yan X; Bai X; Balch CM; Guo J
Ann Surg Oncol; 2018 Aug; 25(8):2184-2192. PubMed ID: 29748886
[TBL] [Abstract][Full Text] [Related]
4. [Analysis of prognostic factors of primary mucosal melanoma in nasal and oral cavity].
Lin JW; Li CW; Wu GH; Zeng ZY
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Jan; 26(2):49-52. PubMed ID: 22500456
[TBL] [Abstract][Full Text] [Related]
5. Survival analysis of malignant melanoma in Japan--multivariate analysis of prognostic factors.
Uehara S; Kamo R; Harada T; Ishii M
Osaka City Med J; 2009 Jun; 55(1):35-52. PubMed ID: 19725433
[TBL] [Abstract][Full Text] [Related]
6. A long-term analysis of 620 patients with malignant melanoma at a major referral center.
Averbook BJ; Russo LJ; Mansour EG
Surgery; 1998 Oct; 124(4):746-55; discussion 755-6. PubMed ID: 9780997
[TBL] [Abstract][Full Text] [Related]
7. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
[TBL] [Abstract][Full Text] [Related]
8. [A clinical and pathological study on primary oral mucosal malignant melanoma].
Chen Y; He Z; Wu L
Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Feb; 21(1):31-3. PubMed ID: 12674617
[TBL] [Abstract][Full Text] [Related]
9. Thick cutaneous malignant melanoma: a reappraisal of prognostic factors.
Massi D; Borgognoni L; Franchi A; Martini L; Reali UM; Santucci M
Melanoma Res; 2000 Apr; 10(2):153-64. PubMed ID: 10803716
[TBL] [Abstract][Full Text] [Related]
10. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
[TBL] [Abstract][Full Text] [Related]
11. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
[TBL] [Abstract][Full Text] [Related]
12. Outcomes in patients with mucosal melanomas.
Keller DS; Thomay AA; Gaughan J; Olszanski A; Wu H; Berger AC; Farma JM
J Surg Oncol; 2013 Dec; 108(8):516-20. PubMed ID: 24132665
[TBL] [Abstract][Full Text] [Related]
13. Level of fluorodeoxyglucose uptake predicts risk for recurrence in melanoma patients presenting with lymph node metastases.
Bastiaannet E; Hoekstra OS; Oyen WJ; Jager PL; Wobbes T; Hoekstra HJ
Ann Surg Oncol; 2006 Jul; 13(7):919-26. PubMed ID: 16788752
[TBL] [Abstract][Full Text] [Related]
14. Independent prognostic importance of vascular invasion in nodular melanomas.
Straume O; Akslen LA
Cancer; 1996 Sep; 78(6):1211-9. PubMed ID: 8826942
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic features and prognostic factors in patients with non-cutaneous malignant melanoma: a single-center retrospective study of 71 cases.
Zhu H; Dong D; Li F; Liu D; Wang L; Fu J; Song L; Xu G
Int J Dermatol; 2015 Dec; 54(12):1390-5. PubMed ID: 26016703
[TBL] [Abstract][Full Text] [Related]
16. Tumor-infiltrating lymphocytes predict cutaneous melanoma survival.
Fortes C; Mastroeni S; Mannooranparampil TJ; Passarelli F; Zappalà A; Annessi G; Marino C; Caggiati A; Russo N; Michelozzi P
Melanoma Res; 2015 Aug; 25(4):306-11. PubMed ID: 25933208
[TBL] [Abstract][Full Text] [Related]
17. The existence of early stage oral mucosal melanoma: A 10-year retrospective analysis of 170 patients in a single institute.
Wu Y; Wang L; Ma X; Guo W; Ren G
Oral Oncol; 2018 Dec; 87():70-76. PubMed ID: 30527246
[TBL] [Abstract][Full Text] [Related]
18. Sarcopenia as a prognostic factor among patients with stage III melanoma.
Sabel MS; Lee J; Cai S; Englesbe MJ; Holcombe S; Wang S
Ann Surg Oncol; 2011 Dec; 18(13):3579-85. PubMed ID: 21822551
[TBL] [Abstract][Full Text] [Related]
19. Value of anatomic site, histology and clinicopathological parameters for prediction of lymph node metastasis and overall survival in head and neck melanomas.
Ettl T; Irga S; Müller S; Rohrmeier C; Reichert TE; Schreml S; Gosau M
J Craniomaxillofac Surg; 2014 Jul; 42(5):e252-8. PubMed ID: 24216129
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in 161 patients with mucosal melanoma: a study of German Central Malignant Melanoma Registry.
Sarac E; Amaral T; Keim U; Leiter U; Forschner A; Eigentler TK; Garbe C
J Eur Acad Dermatol Venereol; 2020 Sep; 34(9):2021-2025. PubMed ID: 32078189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
